These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 32163375)

  • 21. When viruses collide: hepatitis B virus reactivation after hepatitis C treatment.
    Balagopal A; Thio CL
    J Clin Invest; 2020 Jun; 130(6):2823-2826. PubMed ID: 32420916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment of a Cell Culture Model Permissive for Infection by Hepatitis B and C Viruses.
    Otoguro T; Tanaka T; Kasai H; Kobayashi N; Yamashita A; Fukuhara T; Ryo A; Fukai M; Taketomi A; Matsuura Y; Moriishi K
    Hepatol Commun; 2021 Apr; 5(4):634-649. PubMed ID: 33860122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus infection suppresses hepatitis B virus replication via the RIG-I-like helicase pathway.
    Murai K; Hikita H; Kai Y; Kondo Y; Fukuoka M; Fukutomi K; Doi A; Yamai T; Nakabori T; Fukuda R; Takahashi T; Miyakawa K; Suemizu H; Ryo A; Yamada R; Kodama T; Sakamori R; Tatsumi T; Takehara T
    Sci Rep; 2020 Jan; 10(1):941. PubMed ID: 31969598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B Reactivation in Patients Treated with Direct-Acting Antivirals for Hepatitis C.
    Toka B; Köksal AŞ; Dertli R; Şirin G; Fidan S; Ülger Y; Harmandar F; Yıldırım AE; Eminler AT; Asil M; Kayar Y; Bıyık M; Kuran S; Uslan MI; Hülagü S
    Dig Dis; 2022; 40(5):635-643. PubMed ID: 35108715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals.
    Yeh ML; Huang CF; Hsieh MH; Ko YM; Chen KY; Liu TW; Lin YH; Liang PC; Hsieh MY; Lin ZY; Chen SC; Huang CI; Huang JF; Kuo PL; Dai CY; Yu ML; Chuang WL
    J Gastroenterol Hepatol; 2017 Oct; 32(10):1754-1762. PubMed ID: 28230928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.
    Bersoff-Matcha SJ; Cao K; Jason M; Ajao A; Jones SC; Meyer T; Brinker A
    Ann Intern Med; 2017 Jun; 166(11):792-798. PubMed ID: 28437794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature.
    Fabbri G; Mastrorosa I; Vergori A; Mazzotta V; Pinnetti C; Grisetti S; Zaccarelli M; Ammassari A; Antinori A
    BMC Infect Dis; 2017 Mar; 17(1):182. PubMed ID: 28249574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B virus coinfection in patients treated for chronic hepatitis C: clinical characteristics, risk of reactivation with long-term follow-up, and effectiveness of antiviral therapy.
    Zarębska-Michaluk D; Brzdęk M; Rzymski P; Dobrowolska K; Flisiak R
    Pol Arch Intern Med; 2024 Jan; 134(1):. PubMed ID: 38164525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of hepatitis B virus reactivation with direct-acting antivirals against hepatitis C virus: A cohort study from Egypt and meta-analysis of published data.
    El Kassas M; Shimakawa Y; Ali-Eldin Z; Funk AL; Wifi MN; Zaky S; El-Raey F; Esmat G; Fontanet A
    Liver Int; 2018 Dec; 38(12):2159-2169. PubMed ID: 29738637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced host immune responses in presence of HCV facilitate HBV clearance in coinfection.
    Liu S; Zhao K; Su X; Gao X; Yao Y; Kong R; Wang Y; Wu C; Lu M; Chen X; Pei R
    Virol Sin; 2022 Jun; 37(3):408-417. PubMed ID: 35523417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of hepatitis B reactivation among 62,920 veterans treated with oral hepatitis C antivirals.
    Belperio PS; Shahoumian TA; Mole LA; Backus LI
    Hepatology; 2017 Jul; 66(1):27-36. PubMed ID: 28240789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HBV coinfection with HCV alters circulating Tfh cell distribution and impairs HCV neutralizing antibody responses.
    Wen B; Zhang J; Liu W; Tang P; Xie T; Huang L; Hu Y; Jin K; Zhang P; Liu Z; Niu L; Qu X
    J Viral Hepat; 2019 Aug; 26(8):1002-1010. PubMed ID: 30972873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: A systematic review and meta-analysis.
    Chen G; Wang C; Chen J; Ji D; Wang Y; Wu V; Karlberg J; Lau G
    Hepatology; 2017 Jul; 66(1):13-26. PubMed ID: 28195337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis.
    Mücke MM; Backus LI; Mücke VT; Coppola N; Preda CM; Yeh ML; Tang LSY; Belperio PS; Wilson EM; Yu ML; Zeuzem S; Herrmann E; Vermehren J
    Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):172-180. PubMed ID: 29371017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of acute hepatitis B in a chronic hepatitis C patient after daclatasvir and asunaprevir combination therapy: hepatitis B virus reactivation or acute self-limited hepatitis?
    Hayashi K; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Nishimura D; Goto H; Hirooka Y
    Clin J Gastroenterol; 2016 Aug; 9(4):252-6. PubMed ID: 27329484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B reactivation and outcomes in persons treated with directly acting antiviral agents against hepatitis C virus: results from ERCHIVES.
    Butt AA; Yan P; Shaikh OS; Abou-Samra AB
    Aliment Pharmacol Ther; 2018 Feb; 47(3):412-420. PubMed ID: 29181838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues.
    Liu CJ
    J Gastroenterol Hepatol; 2014 Jan; 29(1):26-30. PubMed ID: 24199625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the efficacy of treatment with peginterferon alpha-2a and ribavirin in patients coinfected with hepatitis B virus and hepatitis C virus.
    Yu JW; Sun LJ; Zhao YH; Kang P; Gao J; Li SC
    Liver Int; 2009 Nov; 29(10):1485-93. PubMed ID: 19602134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus/Hepatitis B virus coinfection: Current prospectives.
    Maqsood Q; Sumrin A; Iqbal M; Younas S; Hussain N; Mahnoor M; Wajid A
    Antivir Ther; 2023 Aug; 28(4):13596535231189643. PubMed ID: 37489502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The burden of HBV infection in HCV patients in Italy and the risk of reactivation under DAA therapy.
    Stroffolini T; Sagnelli E; Sagnelli C; Smedile A; Furlan C; Morisco F; Coppola N; Andriulli A; Almasio PL
    Dig Liver Dis; 2019 Mar; 51(3):434-437. PubMed ID: 30361062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.